Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Frederick L. Ruberg, Alexandra Pipilas et al.|Journal of Cardiac Failure|2019Cited by 106
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experienceOmar K. Siddiqi, Frederick L. Ruberg, Gheorghe Doros et al.|Amyloid|2022Cited by 46
Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate ImagingRabah Alreshq, Frederick L. Ruberg, Matthew Cozzolino et al.|The American Journal of Cardiology|2022Cited by 8
Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center ExperienceYuliya Mints, Omar K. Siddiqi, John L. Berk et al.|Circulation|2019Cited by 2
ABNORMAL LIGHT-CHAIN TESTING AND DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS REFERRED FOR TECHNETIUM-99M PYROPHOSPHATE IMAGINGMatthew Cozzolino, Frederick L. Ruberg, Brian Lilleness et al.|Journal of the American College of Cardiology|2021Cited by 0